Evidence map›Paper›PMID 23415960›Full record

ArticleThe American journal of pathology2013

Warfarin accelerates ectopic mineralization in Abcc6(-/-) mice: clinical relevance to pseudoxanthoma elasticum.

Qiaoli Li, Haitao Guo, David W Chou, Dominic J Harrington, Leon J Schurgers, Sharon F Terry, Jouni Uitto

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in The American journal of pathology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03813550 (Intestinal Microbiota and Vitamin K Levels in PXE Patients), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03813550 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Intestinal Microbiota and Vitamin K Levels in PXE Patients (IMPROVE Study)

TypeinterventionalSponsorUniversity Hospital, AngersRan2019 to 2020Enrolled20ConditionsPseudoxanthoma ElasticumArmsFecal and blood samples
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. PXE, a Mysterious Inborn Error Clarified.Trends in biochemical sciences · 2019
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Qiaoli LiDepartment of Dermatology and Cutaneous Biology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Haitao Guo
David W Chou
Dominic J Harrington
Leon J Schurgers
Sharon F Terry
Jouni Uitto
Thomas Jefferson University · USJefferson Institute · USMaastricht University · NLSt Thomas' Hospital · GB

Funding

BIOCHEMISTRY AND MORPHOLOGY OF CONNECTIVE TISSUESR01AR028450 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI UITTO, JOUNI · 1986 to 2019
$6.5M
Model Systems for PXER01AR055225 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI UITTO, JOUNI · 2008 to 2017
$3.2M
NIAMS NIH HHS R01 AR028450NIAMS NIH HHS R01 AR055225NIAMS NIH HHS R01-AR28450NIAMS NIH HHS R01-AR55225
6 · The paper itself

Abstract

Pseudoxanthoma elasticum (PXE) is a multisystem ectopic mineralization disorder caused by mutations in the ABCC6 gene. Warfarin, a commonly used anticoagulant, is associated with increased mineralization of the arterial blood vessels and cardiac valves. We hypothesized that warfarin may accelerate ectopic tissue mineralization in PXE, with clinical consequences. To test this hypothesis, we developed a model in which Abcc6(-/-) mice, which recapitulate features of PXE, were fed a diet supplemented with warfarin and vitamin K1. Warfarin action was confirmed by significantly increased serum levels of oxidized vitamin K. For mice placed on a warfarin-containing diet, quantitative chemical and morphometric analyses revealed massive accumulation of mineral deposits in a number of tissues. Mice fed a warfarin-containing diet were also shown to have abundant uncarboxylated form of matrix Gla protein, which allowed progressive tissue mineralization to ensue. To explore the clinical relevance of these findings, 1747 patients with PXE from the approximately 4000 patients in the PXE International database were surveyed about the use of warfarin. Of the 539 respondents, 2.6% reported past or present use of warfarin. Based on the prevalence of PXE (approximately 1:50,000), thousands of patients with PXE worldwide may be at risk for worsening of PXE as a result of warfarin therapy.

Indexed as

AnimalsATP-Binding Cassette, Sub-Family C ProteinsATP-Binding Cassette TransportersCalcification, PhysiologicCalciumCalcium-Binding ProteinsDermisDietDietary SupplementsDisease Models, AnimalExtracellular Matrix ProteinsHumansMagnesiumMatrix Gla ProteinMiceMineralsAbcc6 protein, mouseATP-Binding Cassette, Sub-Family C ProteinsATP-Binding Cassette TransportersCalciumCalcium-Binding ProteinsExtracellular Matrix ProteinsMagnesiumMatrix Gla ProteinMineralsPhosphatesPhosphorusVitamin KWarfarin

Identifiers

PMID23415960
PMCPMC3620423
OpenAlexW1619629263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.